Abstract
Background Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal tick-borne disease that is widely distributed in Africa and Eurasia countries. It is caused by the CCHF virus of the Nairovirus genus of the Bunyaviridae family.
This study aims to describe the 2018 CCHF epidemic wave in Iraq and epidemiological pattern to assist implantation of preventive and control measures and adherence of physicians to the standard case definition.
Methods This descriptive study reviewed all records of suspected and confirmed CCHF cases. Three types of data sources were used: the case investigation forms of all suspected cases, case sheets of all confirmed cases, and the laboratory results from the central public health laboratory.
Results The total number of suspected cases was 143. Most of the cases were males (59.4%), 15-45 years old (62.2%), and live in urban areas (58.7%). About three quarters of the cases (68.5%) did not fit the standard case definition adopted by Iraq Center of Disease Control. Most of the suspected cases were reported in Diwaniya province (20.3%). Nearly half of them (64, 44.7%) occurred in June.
Only 7.0% (n=10) of suspected cases were positive when tested by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). One third of confirmed cases (3, 30.0%) occurred in Diwaniya province. During the 2018 epidemic wave, there were 10 confirmed cases with 8 deaths and 2 improved cases.
Conclusion Despite the fact that CCHF is uncommon in Iraq, sporadic cases or outbreaks could occur.
Recommendations Given the known method of transmission, banning of random livestock slaughtering and the practice of raising livestock inside residential areas are expected to have a major role in CCHF infection control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Department of Community and Family Medicine, College of Medicine, University of Baghdad whose members were listed below gave ethical approval for this work. 1. Asst Prof. Betool Ali Ghalib: Batool Yassin yassinbat{at}googlemail.com +964-7902-969-407 2. Asst Prof> Nadia Nasir Aziz nadia.aziz2012{at}yahoo.com 00964-7901-616-405 3. Asst Prof. Falah Kareem drfalahkareem{at}yahoo.com
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E.Mail alihazim001122{at}gmail.com, farislami{at}gmail.com, email: drhanan.cdcciq{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors
